Abstract:The transient receptor potential ankyrin 1 (TRPA1) channel plays a pivotal role in the respiratory and gastrointestinal tracts. Within the respiratory system, TRPA1 exhibits diverse distribution patterns across key cell types, including epithelial cells, sensory nerves, and immune cells. Its activation serves as a frontline sensor for inhaled irritants, triggering immediate protective responses, and influencing airway integrity. Furthermore, TRPA1 has been implicated in airway tissue injury, inflammation, and the transition of fibroblasts, thereby posing challenges in conditions, such as severe asthma and fibrosis. In sensory nerves, TRPA1 contributes to nociception, the cough reflex, and bronchoconstriction, highlighting its role in both immediate defense mechanisms and long-term respiratory reflex arcs. In immune cells, TRPA1 may modulate the release of pro-inflammatory mediators, shaping the overall inflammatory landscape. In the gastrointestinal tract, the dynamic expression of TRPA1 in enteric neurons, epithelial cells, and immune cells underscores its multifaceted involvement. It plays a crucial role in gut motility, visceral pain perception, and mucosal defense mechanisms. Dysregulation of TRPA1 in both tracts is associated with various disorders such as asthma, Chronic Obstructive Pulmonary Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Disease. This review emphasizes the potential of TRPA1 as a therapeutic target and discusses the efficacy of TRPA1 antagonists in preclinical studies and their promise for addressing respiratory and gastrointestinal conditions. Understanding the intricate interactions and cross-talk of TRPA1 across different cell types provides insight into its versatile role in maintaining homeostasis in vital physiological systems, offering a foundation for targeted therapeutic interventions.

TRPA1 as a drug target--promise and challenges.

Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective

Distinctive Drug Binding Sites and Gating Mechanisms of the Nociceptive Ion Channel TRPA1

TRPA1-Related Diseases and Applications of Nanotherapy

The TRPA1 channel in the cardiovascular system: promising features and challenges

An updated patent review of TRPA1 antagonists (2020 – present)

Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field

Unveiling the role of TRPA1 in cardiovascular health and disease: a mini review

Research Progress on TRPA1 in Diseases

Irritant-evoked activation and calcium modulation of the TRPA1 receptor

Dual role of transient receptor potential ankyrin 1 in respiratory and gastrointestinal physiology: From molecular mechanisms to therapeutic targets

The Role of TRPA1 in Skin Physiology and Pathology

TRPV1 Channels in the Central Nervous System as Drug Targets

Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action Via Cryogenic Electron Microscopy

Molecular basis of TRPA1 regulation in nociceptive neurons. A review

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases

Inflammation—the role of TRPA1 channel

Transient receptor potential vanilloid 1 as a therapeutic target in analgesia

The Ca 2 1-Permeable Cation Transient Receptor Potential TRPV 3 Channel : An Emerging Pivotal Target for Itch and Skin Diseases

Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management

The pharmacology of TRP channels